Clinical Trials
9 trialsNCT07168837 2025-09-11
Letrozole and Cabergoline Versus Letrozole Alone in Ovulation Induction
Al-Azhar University
Phase NA Completed
NCT01794793 2024-10-01
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies
RECORDATI GROUP
Phase 4 Completed
NCT05981742 2023-08-08
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Al-Rasheed University College
Phase 2 Completed
NCT01730729 2019-09-17
Cabergoline in Metastatic Breast Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT03271918 2017-09-07
Cabergoline in Nonfunctioning Pituitary Adenomas
University of Sao Paulo General Hospital
Phase 3 Completed
NCT00376064 2017-03-06
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Novartis
Phase 4 Completed
NCT01620138 2016-08-22
Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas
Universidade Federal do Rio de Janeiro
Phase 2/3 Completed
NCT01569256 2012-04-04
Ovarian Hyperstimulation Syndrome and Cabergoline
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Phase NA Completed
NCT00889525 2009-04-29
Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Seth Gordhandas Sunderdas Medical College
Phase 3 Completed